Louis J. Lavigne Jr. is a management consultant specializing in the areas of corporate finance accounting and strategy. In March 2005 he retired from 23 years of service with Genentech Inc. a leading publicly traded biotechnology company where he was Executive Vice President and Chief Financial Officer responsible for the company’s financial corporate relations and IT groups. Over his career at Genentech he advanced through a variety of officer positions with greater responsibility-Controller Vice President Senior Vice President and Executive Vice President. During Mr. Lavigne’s tenure Genentech’s annual revenues rose from $40 million in 1983 to $4.6 billion in 2004. In 2005 he was named the Best CFO in Biotech in the Institutional Investor survey.Prior to joining Genentech Mr. Lavigne held various financial management positions with Pennwalt Corporation a chemical and pharmaceutical company.He is a member of the Board of Directors of Allergan Inc. Arena Pharmaceutical Inc. Equinix Kyphon and LifeMasters |